Intervention

GW870086X

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5
Recruiting0
Common conditions1
Lead sponsors shown1
Advertisement

Clinical trials

5 shown
A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.NCT01160003 · 2010-07-29
COMPLETED
A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate AsthmaticsNCT00945932 · 2009-07-01
COMPLETED
A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild AsthmaticsNCT00857857 · 2009-02-16
COMPLETED
A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy VolunteersNCT00549497 · 2007-09-01
COMPLETED
Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male SubjectsNCT00483899 · 2005-10-07
COMPLETED

Trial status mix

COMPLETED5

Phase mix

PHASE13
PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.